$369.00
-10.99-2.89%
Last update: Nov 5, 4:00 PM
Bio-Rad Laboratories Inc
BIONYSE
The average analyst price target for Bio-Rad Laboratories is $340.50, 7.7% below the current price. Of 4 analysts, 2 rate it Buy and 2 Hold. Targets range from $290 to $440. The latest change came on Nov 5, 2026, when RBC Capital raised its price target on Bio-Rad Laboratories from $390 to $440 and kept an Outperform rating.
Price Target Range — 13 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
